GAM 2017

Dolce La Hulpe, Brussels


Dolce La Hulpe
Chaussée de Bruxelles 135
1310 La Hulpe


09 - 11 February 2017

Accreditation (See all)

Activity number 16023327
Credit points: 9.5

This event has finished

Award winners GAM 2017

Best Oral presentation
Sarah Bonte and Tracy Vandergraesen

Best Poster presentation
Melissa Claus, Eva De Smedt, Adeline Rosu and Sophie Van Aelst

On behalf of the Belgian Hematology Society we congratulate them for this great achievement!


Slides invited speakers:

Highlights on rare lymphoproliferative diseases
Lymphomas in the immunocompromised patients - Daan Dierickx
Primary central nervous system lymphoma - Andrés Ferreri, Italy

Advances in laboratory technology
Next generation sequencing in Hematology - Fabrice Jardin, France
Minimal residual disease in acute myeloid leukemia - Peter Valk, the Netherlands

Satellite session 1 sponsored by Bristol-Meyers Squibb Immuno-oncology: a new era in hematology treatment
Making progress with I-O in hematology - Pierre Coulie
PD-1 pathway blockade in classical Hodgkin Lymphoma - Roch Houot, France

Request for the presentations of dr Coulie and dr Houot can be send to: Vanessa Lissens, email or Tom de Foer, email

A new frailty scoring in ‘clinically fit” older patients with malignant hemopathies admitted to receive chemotherapy - Stephanie Dubruille
A single analysis for simultaneous measurement of all 4 DOACs - Jan Emmerechts
Maternal Embryonic Leucine Zipper Kinase (MELK) drives a high-risk gene network and represents an attractive novel drug target in Multiple Myeloma and its associated bone disease - Arnold Bolomsky, Austria
In vitro generation of tumor antigen-specific T cells from patient and healthy donor stem cells - Sarah Bonte
Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia
(AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation - Xavier Poiré
Successful transition from paediatric to adult care in Sickle Cell Disease: An experience in a Belgian center - Tracy Vandergraesen

Special lecture 1
Myelodysplastic syndromes and the new WHO classification - Gregor Verhoef, Belgium

Pierre Stryckmans Lecture
Acute promyelocytic leukemia: state of the art - Francesco Lo Coco, Italy

Satellite session 2 sponsored by Janssen
Treatment of Multiple myeloma in the era of monoclonal antibodies - Niels van de Donk, the Netherlands
Advances in the treatment of Chronic Lymphocytic Leukemia - Paolo Ghia, Italy

Special lecture 2  
Common variable immunodeficiency - Isabelle Meyts
Stopping tyrosine kinase inhibitors in Chronic Myeloid Leukemia - Delphine Rea, France 

Satellite session 3 sponsored by Novartis
New insights in the treatment of Polycythemia Vera patients - Claire Harrison, UK
JAK signaling in hematological malignancies, new horizons - Stefan Constantinescu